Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q2 2026)
4,365,951
Value
$78.5M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of SRPT by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,365,951$78.5M<0.1%+230,163+5.6%AddedHolders
Q1 20264,135,788$90.0M0.1%+2,143,211+107.6%AddedHolders
Q4 20251,992,577$42.9M<0.1%+52,796+2.7%AddedHolders
Q3 20251,939,781$37.4M<0.1%+1,312,220+209.1%AddedHolders
Q2 2025627,561$10.7M<0.1%+233,391+59.2%AddedHolders
Q1 2025394,170$25.2M<0.1%+82,385+26.4%AddedHolders
Q4 2024311,785$37.9M<0.1%−153,131−32.9%ReducedHolders
Q3 2024464,916$58.1M0.1%+363,000+356.2%AddedHolders
Q2 2024101,916$16.1M<0.1%+101,916NewHolders
Q1 20240$00.0%−432,350−100.0%Sold outHolders
Q4 2023432,350$41.7M<0.1%+1,376+0.3%AddedHolders
Q3 2023430,974$52.2M0.1%−173,362−28.7%ReducedHolders
Q2 2023604,336$69.2M0.1%−85,276−12.4%ReducedHolders
Q1 2023689,612$95.0M0.1%−18,334−2.6%ReducedHolders
Q4 2022707,946$91.7M0.1%−209,296−22.8%ReducedHolders
Q3 2022917,242$101.4M0.1%+226,947+32.9%AddedHolders
Q2 2022690,295$51.7M0.1%−169,453−19.7%ReducedHolders
Q1 2022859,748$67.2M0.1%−39,308−4.4%ReducedHolders
Q4 2021899,056$81.0M0.1%−30,152−3.2%ReducedHolders
Q3 2021929,208$85.9M0.1%+56,916+6.5%AddedHolders
Q2 2021872,292$67.8M0.1%−13,579−1.5%ReducedHolders
Q1 2021885,871$66.0M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.